☰

Shahinaz M. Gadalla, Ph.D. - Publications

Affiliations: 
2008 Epidemiology and Preventive Medicine University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Epidemiology, Immunology
Tree Info Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Brown J, Pfeiffer RM, Shrewsbury D, O'Callaghan S, Berner AM, Gadalla SM, Shiels MS, Jackson SS. Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data. The British Journal of General Practice : the Journal of the Royal College of General Practitioners. 73: e486-e492. PMID 37365010 DOI: 10.3399/BJGP.2023.0023  0.309
2023 Pauleck S, Sinnott JA, Zheng YL, Gadalla SM, Viskochil R, Haaland B, Cawthon RM, Hoffmeister A, Hardikar S. Association of Telomere Length with Colorectal Cancer Risk and Prognosis: A Systematic Review and Meta-Analysis. Cancers. 15. PMID 36831502 DOI: 10.3390/cancers15041159  0.369
2022 Patel SS, Ahn KW, Khanal M, Bupp C, Allbee-Johnson M, Majhail NS, Hamilton BK, Rotz SJ, Hashem H, Beitinjaneh A, Lazarus HM, Krem MM, Prestidge T, Bhatt NS, Sharma A, ... Gadalla SM, et al. Non-infectious pulmonary toxicity after allogeneic hematopoietic cell transplantation. Transplantation and Cellular Therapy. PMID 35314376 DOI: 10.1016/j.jtct.2022.03.015  0.309
2021 Menghrajani K, Gomez-Arteaga A, Madero-Marroquin R, Zhang MJ, Bo-Subait K, Sanchez J, Wang HL, Aljurf M, Assal A, Bacher U, Badawy SM, Bejanyan N, Bhatt VR, Bredeson CN, Byrne M, ... ... Gadalla SM, et al. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood Advances. PMID 34551064 DOI: 10.1182/bloodadvances.2021004881  0.32
2020 Schairer C, Hablas A, Eldein IAS, Gaafar R, Rais H, Mezlini A, Ayed FB, Ayoub WB, Benider A, Tahri A, Khouchani M, Aboulazm D, Karkouri M, Eissa S, Bastawisy AE, ... ... Gadalla SM, et al. Risk factors for inflammatory and non-inflammatory breast cancer in North Africa. Breast Cancer Research and Treatment. PMID 32876910 DOI: 10.1007/S10549-020-05864-3  0.324
2019 Alsaggaf R, Pfeiffer RM, Wang Y, St George DMM, Zhan M, Wagner KR, Amr S, Greene MH, Gadalla SM. Diabetes, Metformin, and Cancer Risk in Myotonic Dystrophy Type I. International Journal of Cancer. PMID 31749144 DOI: 10.1002/Ijc.32801  0.594
2019 Busby J, Karasneh R, Murchie P, McMenamin Ú, Gadalla SM, Camargo MC, Iversen L, Lee AJ, Spence AD, Cardwell CR. The role of 5α-reductase inhibitors in gastro-oesophageal cancer risk: A nested case-control study. Pharmacoepidemiology and Drug Safety. PMID 31713940 DOI: 10.1002/pds.4909  0.317
2019 Higgs C, Hilbert JE, Wood L, Martens WB, Marini-Bettolo C, Nikolenko N, Alsaggaf R, Lochmüller H, Moxley RT, Greene MH, Wang Y, Gadalla SM. Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM Registries. Frontiers in Neurology. 10: 1071. PMID 31681146 DOI: 10.3389/fneur.2019.01071  0.322
2019 Alsaggaf R, St George DMM, Zhan M, Pfeiffer RM, Wang Y, Anderson LA, Liu Z, Koshiol J, Bauer AJ, Wagner KR, Greene MH, Amr S, Gadalla SM. Benign tumors in myotonic dystrophy type I target disease-related cancer sites. Annals of Clinical and Translational Neurology. 6: 1510-1518. PMID 31402615 DOI: 10.1002/Acn3.50856  0.573
2018 Alsaggaf R, St George DMM, Zhan M, Pfeiffer RM, Wang Y, Wagner KR, Greene MH, Amr S, Gadalla SM. Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity. Jnci Cancer Spectrum. 2: pky052. PMID 30556050 DOI: 10.1093/Jncics/Pky052  0.583
2018 Liu Z, Alsaggaf R, McGlynn KA, Anderson LA, Tsai HT, Zhu B, Zhu Y, Mbulaiteye SM, Gadalla SM, Koshiol J. Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink. Gut. PMID 30448774 DOI: 10.1136/Gutjnl-2018-317504  0.342
2018 Best A, Hilbert JE, Wood L, Martens WB, Nikolenko N, Marini-Bettolo C, Lochmüller H, Rosenberg PS, Moxley RT, Greene MH, Gadalla SM. Survival Patterns and Cancer Determinants in Families with Myotonic Dystrophy Type I. European Journal of Neurology. PMID 30051542 DOI: 10.1111/ene.13763  0.305
2018 Emparanza JI, de Munain AL, Greene MH, Matheu A, Fernández-Torrón R, Gadalla SM. Cancer Phenotype in Myotonic Dystrophy Patients: Results from a Meta-analysis. Muscle & Nerve. PMID 30028904 DOI: 10.1002/mus.26194  0.393
2017 Schairer C, Pfeiffer RM, Gadalla SM. Autoimmune diseases and breast cancer risk by tumor hormone-receptor status among elderly women. International Journal of Cancer. PMID 29144542 DOI: 10.1002/ijc.31148  0.391
2017 Wang Y, Pfeiffer RM, Alsaggaf R, Meeraus W, Gage JC, Anderson LA, Bremer RC, Nikolenko N, Lochmuller H, Greene MH, Gadalla SM. Risk of skin cancer among patients with myotonic dystrophy type 1 based on Primary care physician data from the United Kingdom Clinical Practice Research Datalink. International Journal of Cancer. PMID 29114849 DOI: 10.1002/ijc.31143  0.379
2017 Schairer C, Gadalla SM, Pfeiffer RM, Moore SC, Engels EA. Diabetes, Abnormal Glucose, Dyslipidemia, Hypertension and Risk of Inflammatory and Other Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28087608 DOI: 10.1158/1055-9965.EPI-16-0647  0.315
2016 Bianchi ML, Leoncini E, Masciullo M, Modoni A, Gadalla SM, Massa R, Rastelli E, Terracciano C, Antonini G, Bucci E, Petrucci A, Costanzi S, Santoro M, Boccia S, Silvestri G. Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors. Journal of Neurology. PMID 26739382 DOI: 10.1007/s00415-015-8006-y  0.368
2015 Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, ... ... Gadalla S, et al. Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 266-74. PMID 25445023 DOI: 10.1016/J.Bbmt.2014.10.021  0.353
2013 Gadalla SM, Pfeiffer RM, Kristinsson SY, Björkholm M, Hilbert JE, Moxley RT, Landgren O, Greene MH. Quantifying cancer absolute risk and cancer mortality in the presence of competing events after a myotonic dystrophy diagnosis. Plos One. 8: e79851. PMID 24236163 DOI: 10.1371/journal.pone.0079851  0.398
2013 Walcott F, Rajaraman P, Gadalla SM, Inskip PD, Purdue MP, Albanes D, Orr E, De Vivo I, Savage SA. Telomere length and risk of glioma. Cancer Epidemiology. 37: 935-8. PMID 24231251 DOI: 10.1016/J.Canep.2013.10.002  0.31
2012 Das M, Moxley RT, Hilbert JE, Martens WB, Letren L, Greene MH, Gadalla SM. Correlates of tumor development in patients with myotonic dystrophy. Journal of Neurology. 259: 2161-6. PMID 22619053 DOI: 10.1007/S00415-012-6476-8  0.393
2011 Gadalla SM, Lund M, Pfeiffer RM, Gørtz S, Mueller CM, Moxley RT, Kristinsson SY, Björkholm M, Shebl FM, Hilbert JE, Landgren O, Wohlfahrt J, Melbye M, Greene MH. Cancer risk among patients with myotonic muscular dystrophy. Jama. 306: 2480-6. PMID 22166607 DOI: 10.1001/Jama.2011.1796  0.445
2011 Gadalla SM, Rajan A, Pfeiffer R, Kristinsson SY, Björkholm M, Landgren O, Giaccone G. A population-based assessment of mortality and morbidity patterns among patients with thymoma. International Journal of Cancer. Journal International Du Cancer. 128: 2688-94. PMID 20669226 DOI: 10.1002/Ijc.25583  0.48
2010 Mirabello L, Savage SA, Korde L, Gadalla SM, Greene MH. LINE-1 methylation is inherited in familial testicular cancer kindreds. Bmc Medical Genetics. 11: 77. PMID 20478068 DOI: 10.1186/1471-2350-11-77  0.426
2009 Korde LA, Gadalla SM. Cancer risk assessment for the primary care physician. Primary Care. 36: 471-88. PMID 19616151 DOI: 10.1016/J.Pop.2009.04.006  0.445
2009 Anderson LA, Gadalla S, Morton LM, Landgren O, Pfeiffer R, Warren JL, Berndt SI, Ricker W, Parsons R, Engels EA. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. International Journal of Cancer. Journal International Du Cancer. 125: 398-405. PMID 19365835 DOI: 10.1002/Ijc.24287  0.37
2009 Anderson LA, Pfeiffer RM, Landgren O, Gadalla S, Berndt SI, Engels EA. Risks of myeloid malignancies in patients with autoimmune conditions. British Journal of Cancer. 100: 822-8. PMID 19259097 DOI: 10.1038/Sj.Bjc.6604935  0.41
2009 Gadalla SM, Amr S, Langenberg P, Baumgarten M, Davidson WF, Schairer C, Engels EA, Pfeiffer RM, Goedert JJ. Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case-control study. British Journal of Cancer. 100: 817-21. PMID 19190628 DOI: 10.1038/Sj.Bjc.6604906  0.581
2008 Anderson LA, Pfeiffer R, Warren JL, Landgren O, Gadalla S, Berndt SI, Ricker W, Parsons R, Wheeler W, Engels EA. Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3069-75. PMID 18957521 DOI: 10.1158/1055-9965.Epi-08-0408  0.305
2008 Royak-Schaler R, Passmore SR, Gadalla S, Hoy MK, Zhan M, Tkaczuk K, Harper LM, Nicholson PD, Hutchison AP. Exploring patient-physician communication in breast cancer care for African American women following primary treatment. Oncology Nursing Forum. 35: 836-43. PMID 18765331 DOI: 10.1188/08.Onf.836-843  0.344
2006 Ling H, Gadalla S, Israel E, Langenberg P, Zhan M, Dwyer DM, Groves C, Hopkins A, Steinberger EK. Oral cancer exams among cigarette smokers in Maryland. Cancer Detection and Prevention. 30: 499-506. PMID 17113720 DOI: 10.1016/J.Cdp.2006.10.005  0.306
2006 Royak-Schaler R, Gadalla SM, Lemkau JP, Ross DD, Alexander C, Scott D. Family perspectives on communication with healthcare providers during end-of-life cancer care Oncology Nursing Forum. 33: 753-760. PMID 16858457 DOI: 10.1188/06.Onf.753-760  0.317
Show low-probability matches.